Applied Therapeutics, Inc. (NASDAQ:APLT) Shares Sold by Ergoteles LLC
Applied Therapeutics, Inc. (NASDAQ:APLT) Shares Sold by Ergoteles LLC
Ergoteles LLC lowered its position in Applied Therapeutics, Inc. (NASDAQ:APLT – Get Rating) by 40.3% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 51,685 shares of the company's stock after selling 34,915 shares during the quarter. Ergoteles LLC owned 0.11% of Applied Therapeutics worth $48,000 as of its most recent filing with the Securities and Exchange Commission.
根據其最近與證券交易委員會的披露，Ergoteles LLC 在第三季度將其在應用治療學公司（NASDAQ：APLT-獲得評級）的地位下降了 40.3%。本季度出售 34,915 股股票後，該基金擁有該公司股票的 51,685 股股份。Ergoteles LLC 擁有應用治療的 0.11％，價值 48,000 美元，截至最近在證券交易委員會提交的文件中。
A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in APLT. Franklin Resources Inc. boosted its holdings in Applied Therapeutics by 199.3% in the second quarter. Franklin Resources Inc. now owns 4,775,484 shares of the company's stock valued at $4,528,000 after acquiring an additional 3,179,934 shares during the last quarter. FMR LLC boosted its holdings in Applied Therapeutics by 343.6% in the second quarter. FMR LLC now owns 4,007,283 shares of the company's stock valued at $3,800,000 after acquiring an additional 3,103,990 shares during the last quarter. Laurion Capital Management LP acquired a new position in Applied Therapeutics in the second quarter valued at $328,000. Point72 Asset Management L.P. lifted its stake in shares of Applied Therapeutics by 11.2% during the second quarter. Point72 Asset Management L.P. now owns 2,835,000 shares of the company's stock worth $2,688,000 after purchasing an additional 286,000 shares in the last quarter. Finally, Renaissance Technologies LLC lifted its stake in shares of Applied Therapeutics by 1,503.4% during the first quarter. Renaissance Technologies LLC now owns 282,200 shares of the company's stock worth $595,000 after purchasing an additional 264,600 shares in the last quarter. Institutional investors and hedge funds own 62.94% of the company's stock.
一些其他對沖基金和其他機構投資者最近也增加或減少了他們在 APLT 的股份。富蘭克林資源公司在第二季度將其在應用治療領域的控股提高了 199.3％。富蘭克林資源股份有限公司在上一季度額外購入 3,179,934 股股份後，擁有該公司股票價值 4,528,000 元的 4,775,484 股股份。FMR LLC 在第二季度將其在應用治療學的持有量提高了 343.6％。在上一季度額外收購 3,103,990 股股票後，FMR 有限責任公司現在擁有該公司股票的 4,007,283 股價值 3,800,000 美元。勞永資本管理 LP 在第二季度收購了應用治療學的新職位，價值為 328,000 美元。第二季度，Point72 資產管理有限責任公司將其應用治療學股份的股份提升了 11.2％。七十二點資產管理有限公司在上一季額外購買 286,000 股股份後，擁有該公司股票價值 2,688,000 美元的 2,835,000 股股份。最後，文藝復興技術有限責任公司在第一季度將其在應用治療的股份中取消了 1,503.4％。文藝復興科技有限責任公司現在擁有該公司股票的 282,200 股價值 595,000 美元在上一個季度額外購買 264,600 股股票後。機構投資者和對沖基金擁有公司股票的 62.94％。
Applied Therapeutics Price Performance
應用治療價格表現
Shares of APLT opened at $0.93 on Friday. The stock's 50-day moving average is $1.01 and its two-hundred day moving average is $0.97. The stock has a market cap of $44.62 million, a PE ratio of -0.28 and a beta of 1.90. Applied Therapeutics, Inc. has a 12 month low of $0.50 and a 12 month high of $2.73.
APLT 股票在周五以 0.93 美元開盤。該股票的 50 天移動平均線為 1.01 美元，其 200 日移動平均線為 0.97 美元。該股的市值為 4,462 萬美元，私募股票比率為 -0.28，測試值為 1.90。應用治療學公司擁有 12 個月低點 0.50 美元，12 個月高點為 2.73 美元。
Applied Therapeutics Profile
應用治療概況
(Get Rating)
(取得評分)
Applied Therapeutics, Inc is a clinical-stage biopharmaceutical company which engages in the development of a pipeline of novel products. It is targeting treatments for central nervous system rare diseases and diabetic complications. The company was founded by Shoshana Shendelman on January 20, 2016 and is headquartered in New York, NY.
應用治療, Inc. 是一家臨床階段的生物製藥公司，致力於開發一系列新穎產品。它的目標是治療中樞神經系統罕見疾病和糖尿病並發症.該公司由肖莎娜·申德曼於 2016 年 1 月 20 日創立，總部位於紐約州紐約。
Further Reading
進一步閱讀
- Get a free copy of the StockNews.com research report on Applied Therapeutics (APLT)
- Fossil Group: Should You Bet On Consumer Discretionary In 2023?
- BJ's Wholesale Club Stock Moves Higher After Strong Results
- Monthly Realty Income is About to Get Bigger
- 3 Large Cap Dividend Challengers for Millennial Investors
- Sea Ltd Is On The Verge Of A 100% Rally, Should You Buy?
- 獲取有關應用治療研究報告的免費副本
- 化石集團：您應該在 2023 年押注自由消費嗎？
- BJ 批發俱樂部股票在強勁業績後走高
- 每月房地產收入即將變得更大
- 3 千禧一代投資者的大型股息挑戰者
- Sea 有限公司處於 100％ 拉力賽的邊緣，您應該購買嗎？
Receive News & Ratings for Applied Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Applied Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
每日接收應用治療學的新聞和評分 -在下面輸入您的電子郵件地址，以通過 MarketBeat.com 的免費每日電子郵件通訊接收有關應用治療及相關公司的最新新聞和分析師評級的簡要每日摘要。
譯文內容由第三人軟體翻譯。